These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Case Report: Successful Treatment of Pulmonary Talaromyces marneffei Infection with Posaconazole in a Renal Transplant Recipient. Lang Q, Pasheed Chughtai A, Kong WF, Yan HY. Am J Trop Med Hyg; 2020 Nov 23; 104(2):744-747. PubMed ID: 33236714 [Abstract] [Full Text] [Related]
24. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. Supparatpinyo K, Schlamm HT. Am J Trop Med Hyg; 2007 Aug 23; 77(2):350-3. PubMed ID: 17690411 [Abstract] [Full Text] [Related]
29. Pneumonia caused by Talaromyces marneffei in an epidermal growth factor receptor (EGFR) mutation-positive advanced lung adenocarcinoma patient: a case report. Liu W, Xu J, Lin B, Zhang Y, Xie F, Zhou C, Lai G, Zhang L, Yu Z. Ann Palliat Med; 2021 Jan 23; 10(1):759-766. PubMed ID: 33440949 [Abstract] [Full Text] [Related]
30. An Overlooked and Underrated Endemic Mycosis-Talaromycosis and the Pathogenic Fungus Talaromyces marneffei. Wang F, Han R, Chen S. Clin Microbiol Rev; 2023 Mar 23; 36(1):e0005122. PubMed ID: 36648228 [Abstract] [Full Text] [Related]
31. Talaromyces marneffei infection in non-HIV-infected patients in mainland China. He L, Mei X, Lu S, Ma J, Hu Y, Mo D, Chen X, Fan R, Xi L, Xie T. Mycoses; 2021 Oct 23; 64(10):1170-1176. PubMed ID: 34110649 [Abstract] [Full Text] [Related]
32. Multiple intracranial space-occupying lesions caused by Talaromyces marneffei infection in an AIDS patient returning from Cambodia. Zhu X, Liu X, Cao Q, Dai B, Xiong Y, Zhou H, Zheng J, Zhu B. Travel Med Infect Dis; 2022 Oct 23; 50():102477. PubMed ID: 36257592 [No Abstract] [Full Text] [Related]
33. Administration of Voriconazole in Disseminated Talaromyces (Penicillium) Marneffei Infection: A Retrospective Study. Ouyang Y, Cai S, Liang H, Cao C. Mycopathologia; 2017 Jun 23; 182(5-6):569-575. PubMed ID: 28108867 [Abstract] [Full Text] [Related]
34. Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China. Lei HL, Li LH, Chen WS, Song WN, He Y, Hu FY, Chen XJ, Cai WP, Tang XP. Eur J Clin Microbiol Infect Dis; 2018 Jun 23; 37(6):1099-1102. PubMed ID: 29536323 [Abstract] [Full Text] [Related]
35. Talaromycosis clinically and histopathologically mimicking histoplasmosis in an immunocompromised patient. Widaty S, Santoso ID, Ricky D, Yunihastuti E, Rihatmadja R, Wahyuningsih R. Dermatol Online J; 2020 Sep 15; 26(9):. PubMed ID: 33054937 [Abstract] [Full Text] [Related]
36. A Talaromyces marneffei infection with osteolytic lesions in an HIV-negative patient at non-endemic areas: A case report. Chen Y. SAGE Open Med Case Rep; 2020 Sep 15; 8():2050313X20938242. PubMed ID: 32670581 [Abstract] [Full Text] [Related]
37. Talaromyces marneffei endocarditis initially detected by Next Generation Sequencing: A case report. Ji Y, Zhuo B, Jiang T, Chen M, Xu W, Shen Y, Cheng D, Ge Y. Int J Med Microbiol; 2024 Mar 15; 314():151615. PubMed ID: 38394877 [Abstract] [Full Text] [Related]
38. Rare misdiagnosed case of penicilliosis marneffei in an immunocompetent patient. Cheng D, Ding X. J Int Med Res; 2020 Oct 15; 48(10):300060520959484. PubMed ID: 33100074 [Abstract] [Full Text] [Related]
39. Talaromyces Marneffei Infection in an HIV-Negative Child with a CARD9 Mutation in China: A Case Report and Review of the Literature. You CY, Hu F, Lu SW, Pi DD, Xu F, Liu CJ, Fu YQ. Mycopathologia; 2021 Aug 15; 186(4):553-561. PubMed ID: 34224076 [Abstract] [Full Text] [Related]
40. Voriconazole Versus Amphotericin B as Induction Therapy for Talaromycosis in HIV/AIDS Patients: A Retrospective Study. Huang W, Li T, Zhou C, Wei F, Cao C, Jiang J. Mycopathologia; 2021 May 15; 186(2):269-276. PubMed ID: 33616828 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]